期刊
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 55, 期 22, 页码 2413-2426出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2009.10.085
关键词
aortic valve replacement; mitral valve replacement; mechanical heart valve; bioprosthesis; homograft; autograft
In the last 7 years, more data have reconfirmed that patients' comorbid conditions are very important factors determining patient outcomes. Prosthetic heart valves (PHVs) that require aortic root replacement in the absence of aortic root disease are associated with poorer outcomes. For the vast majority of patients, the choice of PHV is between a mechanical valve and a stented bioprosthesis. The choice is largely dependent upon the age of the patient at the time of PHV implantation and on which complication the patient wants to avoid: specifically, anticoagulation therapy and its complications with the mechanical valve, and structural valve deterioration with a bioprosthesis. Data on the pros and cons of the choices and exceptions to the rules are discussed, and a new algorithm is developed. (J Am Coll Cardiol 2010; 55: 2413-26) (C) 2010 by the American College of Cardiology Foundation
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据